Next Article in Journal
Impact of mRNA and Inactivated COVID-19 Vaccines on Ovarian Reserve
Next Article in Special Issue
Venous Thromboembolic Risk Does Not Increase After a Third Dose of SARS-CoV-2 mRNA-BNT162b2 Vaccine in Cancer Patients Receiving Active Systemic Therapies: Updated Results from the Vax-On-Third-Profile Study
Previous Article in Journal
The Evaluation of a Porcine Circovirus Type 2 (PCV2) Intradermal Vaccine Against a PCV2 Field Strain
Previous Article in Special Issue
Targeted Delivery of Personalized Cancer Vaccines Based on Antibody–Antigen Complexes
 
 
Review

Article Versions Notes

Vaccines 2025, 13(4), 344; https://doi.org/10.3390/vaccines13040344
Action Date Notes Link
article xml file uploaded 24 March 2025 11:55 CET Original file -
article xml uploaded. 24 March 2025 11:55 CET Update https://www.mdpi.com/2076-393X/13/4/344/xml
article pdf uploaded. 24 March 2025 11:55 CET Version of Record https://www.mdpi.com/2076-393X/13/4/344/pdf
article html file updated 24 March 2025 11:56 CET Original file https://www.mdpi.com/2076-393X/13/4/344/html
Back to TopTop